HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
98:@0.083944:0.033217:0.104640:0.033217:0.104640:0.013052:0.083944:0.013052:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
scribed to achieve a target of 10-12 gm %. The normali-:@0.076190:0.084931:0.480957:0.084931:0.480957:0.069149:0.076190:0.069149:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.004203:0.005125:0.009903:0.004188:0.010326:0.009782:0.009223:0.003024:0.009827:0.008376:0.009827:0.004203:0.010326:0.004203:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.004188:0.009903:0.004747:0.004203:0.008376:0.008376:0.005020:0.008376:0.008376:0.004218:0.010175:0.014182:0.004203:0.011717:0.004188:0.004203:0.006441:0.009223:0.009827:0.004188:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005020
sation of the Hb with erythropoietin, especially with high :@0.076190:0.099271:0.485160:0.099271:0.485160:0.083488:0.076190:0.083488:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.003916:0.009903:0.004747:0.003916:0.005125:0.009223:0.009827:0.003901:0.010326:0.010311:0.003916:0.012564:0.003024:0.005125:0.009223:0.003916:0.009827:0.004551:0.008104:0.005125:0.009223:0.004551:0.009903:0.010311:0.009888:0.003024:0.009827:0.005125:0.003024:0.009223:0.004188:0.003916:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.003931:0.012564:0.003024:0.005125:0.009223:0.003916:0.009223:0.003024:0.010175:0.009223:0.004188
doses, may increase the risk of CV events.:@0.076190:0.113610:0.381746:0.113610:0.381746:0.097828:0.076190:0.097828:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188:0.004188:0.014182:0.010326:0.008104:0.004188:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.004188:0.005125:0.009223:0.009827:0.004188:0.004551:0.003024:0.005866:0.007590:0.004188:0.009903:0.004747:0.004188:0.012292:0.010614:0.004188:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004188
11:@0.381723:0.108301:0.391440:0.108301:0.391440:0.099147:0.381723:0.099147:0.004858:0.004858
bone health:@0.076190:0.145004:0.173288:0.145004:0.173288:0.126672:0.076190:0.126672:0.009743:0.010751:0.010079:0.010751:0.004704:0.010079:0.010751:0.011087:0.004032:0.005040:0.010079
In advanced CKD, the  kidney has a limited ability  to :@0.076190:0.161510:0.485145:0.161510:0.485145:0.145727:0.076190:0.145727:0.003417:0.009223:0.006925:0.010326:0.010357:0.008376:0.010326:0.009223:0.009782:0.009827:0.010357:0.006925:0.012292:0.008935:0.011249:0.004188:0.006925:0.005125:0.009223:0.009827:0.004188:0.002721:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.006925:0.009223:0.010326:0.005866:0.006925:0.010326:0.006925:0.003024:0.003024:0.014182:0.003024:0.005125:0.009827:0.010357:0.006925:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188:0.002752:0.005125:0.009903:0.004188
excrete  phosphate, and there  is reduced conversion :@0.076190:0.175849:0.485130:0.175849:0.485130:0.160067:0.076190:0.160067:0.009827:0.007257:0.009782:0.004551:0.009827:0.005125:0.009827:0.004188:0.003024:0.010311:0.009223:0.009903:0.005866:0.010311:0.009223:0.010326:0.005125:0.009827:0.004188:0.007227:0.010326:0.009223:0.010357:0.007227:0.005125:0.009223:0.009827:0.004551:0.009827:0.004188:0.003024:0.003024:0.005866:0.007227:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.007227:0.009782:0.009903:0.009223:0.008376:0.009827:0.004551:0.005866:0.003024:0.009903:0.009223:0.004188
of cholecalciferol to active vitamin D in the kidney, re-:@0.076190:0.190189:0.480957:0.190189:0.480957:0.174406:0.076190:0.174406:0.009903:0.004747:0.005125:0.009782:0.009223:0.009903:0.003024:0.009827:0.009782:0.010326:0.003024:0.009782:0.003024:0.004747:0.009827:0.004551:0.009903:0.003024:0.005140:0.005125:0.009903:0.005125:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.005140:0.008376:0.003024:0.005125:0.010326:0.014182:0.003024:0.009223:0.005140:0.011249:0.005140:0.003024:0.009223:0.005140:0.005125:0.009223:0.009827:0.005125:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.004188:0.005140:0.004551:0.009827:0.005020
ducing calcium absorption and mineralisation of bone. :@0.076190:0.204528:0.485130:0.204528:0.485130:0.188745:0.076190:0.188745:0.010357:0.009192:0.009782:0.003024:0.009223:0.010175:0.004415:0.009782:0.010326:0.003024:0.009782:0.003024:0.009192:0.014182:0.004415:0.010326:0.010311:0.005866:0.009903:0.004551:0.010311:0.005125:0.003024:0.009903:0.009223:0.004415:0.010326:0.009223:0.010357:0.004415:0.014182:0.003024:0.009223:0.009827:0.004551:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004415:0.009903:0.004747:0.004415:0.010311:0.009903:0.009223:0.009827:0.004188:0.004188
The net effect is increased phosphate and low calcium :@0.076190:0.218868:0.485130:0.218868:0.485130:0.203085:0.076190:0.203085:0.006441:0.009223:0.009827:0.004309:0.009223:0.009827:0.005125:0.004309:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004309:0.003024:0.005866:0.004324:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004324:0.010311:0.009223:0.009903:0.005866:0.010311:0.009223:0.010326:0.005125:0.009827:0.004309:0.010326:0.009223:0.010357:0.004324:0.003024:0.009903:0.012564:0.004324:0.009782:0.010326:0.003024:0.009782:0.003024:0.009192:0.014182:0.004188
that  stimulates  parathyroid  hormone  (pTH)  (and FGF-:@0.076190:0.233207:0.480927:0.233207:0.480927:0.217424:0.076190:0.217424:0.005125:0.009223:0.010326:0.005125:0.004188:0.003402:0.005866:0.005125:0.003024:0.014182:0.009192:0.003024:0.010326:0.005125:0.009827:0.005866:0.004188:0.003402:0.010311:0.010326:0.004551:0.010326:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.004188:0.003402:0.009223:0.009903:0.004551:0.014182:0.009903:0.009223:0.009827:0.004188:0.003387:0.005579:0.008950:0.006441:0.010326:0.005579:0.004188:0.003402:0.005579:0.010326:0.009223:0.010357:0.007605:0.007333:0.013184:0.007333:0.005020
23) to  promote  excretion  of  phosphate  and  mobilise :@0.076190:0.247546:0.485130:0.247546:0.485130:0.231764:0.076190:0.231764:0.008376:0.008376:0.005579:0.007333:0.005125:0.009903:0.004188:0.003130:0.010311:0.004551:0.009903:0.014182:0.009903:0.005125:0.009827:0.004188:0.003130:0.009827:0.007257:0.009782:0.004551:0.009827:0.005125:0.003024:0.009903:0.009223:0.004188:0.003130:0.009903:0.004747:0.004188:0.003130:0.010311:0.009223:0.009903:0.005866:0.010311:0.009223:0.010326:0.005125:0.009827:0.004188:0.003130:0.010326:0.009223:0.010357:0.004188:0.003130:0.014182:0.009903:0.010311:0.003024:0.003024:0.003024:0.005866:0.009827:0.004188
Ca  from bone. This results in secondary hyperparathy-:@0.076190:0.261886:0.480972:0.261848:0.480972:0.246065:0.076190:0.246103:0.012292:0.010326:0.010629:0.004505:0.004747:0.004551:0.009888:0.014182:0.004505:0.010311:0.009903:0.009223:0.009827:0.004188:0.004505:0.006441:0.009223:0.003024:0.005866:0.004505:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.004505:0.003024:0.009223:0.004505:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.010326:0.004551:0.008104:0.004490:0.009223:0.008104:0.010311:0.009827:0.004551:0.010311:0.010326:0.004551:0.010326:0.005125:0.009223:0.008104:0.511343
++:@0.098810:0.256549:0.109438:0.256549:0.109438:0.247395:0.098810:0.247395:0.005314:0.005314
roidism and, combined with vitamin D deficiency, caus:@0.076190:0.276187:0.475907:0.276187:0.475907:0.260405:0.076190:0.260405:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.003855:0.010326:0.009223:0.010357:0.004188:0.003855:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.009827:0.010357:0.003855:0.012564:0.003024:0.005125:0.009223:0.003855:0.008376:0.003024:0.005125:0.010326:0.014182:0.003024:0.009223:0.003870:0.011249:0.003855:0.010357:0.009827:0.003681:0.003681:0.009782:0.003024:0.009827:0.009223:0.009782:0.008104:0.004188:0.003855:0.009782:0.010326:0.009192:0.005866
-:@0.475907:0.276187:0.480927:0.276187:0.480927:0.260405:0.475907:0.260405:0.005020
es renal osteodystrophy and increased CV events. This :@0.076190:0.290527:0.485130:0.290527:0.485130:0.274744:0.076190:0.274744:0.009827:0.005866:0.005337:0.004551:0.009827:0.009223:0.010326:0.003024:0.005337:0.009903:0.005866:0.005125:0.009827:0.009903:0.010357:0.008104:0.005866:0.005125:0.004551:0.009903:0.010311:0.009223:0.008104:0.005337:0.010326:0.009223:0.010357:0.005337:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.005337:0.012292:0.010614:0.005337:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004188:0.005337:0.006441:0.009223:0.003024:0.005866:0.004188
usually becomes a clinically relevant issue at CKD stage :@0.076190:0.304866:0.485145:0.304866:0.485145:0.289084:0.076190:0.289084:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.003795:0.010311:0.009827:0.009782:0.009903:0.014182:0.009827:0.005866:0.003795:0.010326:0.003795:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.003810:0.004551:0.009827:0.003024:0.009827:0.008376:0.010326:0.009223:0.005125:0.003795:0.003024:0.005866:0.005866:0.009192:0.009827:0.003795:0.010326:0.005125:0.003795:0.012292:0.008935:0.011249:0.003795:0.005866:0.005125:0.010326:0.010175:0.009827:0.004188
3b, and it is necessary to monitor Ca , phosphate, alka-:@0.076190:0.319206:0.480933:0.319184:0.480933:0.303401:0.076190:0.303423:0.008376:0.010311:0.004188:0.003629:0.010326:0.009223:0.010357:0.003629:0.003024:0.005125:0.003629:0.003024:0.005866:0.003629:0.009223:0.009827:0.009782:0.009827:0.005866:0.005866:0.010326:0.004551:0.008104:0.003629:0.005125:0.009903:0.003613:0.014182:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.003613:0.012292:0.010326:0.010619:0.004188:0.003613:0.010311:0.009223:0.009903:0.005866:0.010311:0.009223:0.010326:0.005125:0.009827:0.004188:0.003613:0.010326:0.003024:0.007590:0.010326:0.436300
++:@0.338301:0.313885:0.348929:0.313885:0.348929:0.304731:0.338301:0.304731:0.005314:0.005314
line phosphatase, and pTH. Treatment is to reduce phos-:@0.076196:0.333523:0.480963:0.333523:0.480963:0.317741:0.076196:0.317741:0.003024:0.003024:0.009223:0.009827:0.003372:0.010311:0.009223:0.009903:0.005866:0.010311:0.009223:0.010326:0.005125:0.010326:0.005866:0.009827:0.004188:0.003372:0.010326:0.009223:0.010357:0.003372:0.008950:0.006441:0.010326:0.004188:0.003372:0.006441:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003356:0.003024:0.005866:0.003372:0.005125:0.009903:0.003372:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.003372:0.010311:0.009223:0.009903:0.005866:0.005020
phate intake, the use of phosphate binders (e.g., cal-:@0.076196:0.347863:0.480948:0.347863:0.480948:0.332080:0.076196:0.332080:0.010311:0.009223:0.010326:0.005125:0.009827:0.005927:0.003024:0.009223:0.005125:0.010326:0.007590:0.009827:0.004188:0.005912:0.005125:0.009223:0.009827:0.005912:0.009192:0.005866:0.009827:0.005927:0.009903:0.004747:0.005912:0.010311:0.009223:0.009903:0.005866:0.010311:0.009223:0.010326:0.005125:0.009827:0.005927:0.010311:0.003024:0.009223:0.010357:0.009827:0.004551:0.005866:0.005927:0.005579:0.009827:0.004188:0.010175:0.004188:0.004188:0.005912:0.009782:0.010326:0.003024:0.005020
cium carbonate 1-2 tablets with meals, or sevelamer) :@0.076196:0.362202:0.485136:0.362202:0.485136:0.346420:0.076196:0.346420:0.009782:0.003024:0.009192:0.014182:0.006380:0.009782:0.010326:0.004551:0.010311:0.009903:0.009223:0.010326:0.005125:0.009827:0.006365:0.008376:0.005020:0.008376:0.006380:0.005125:0.010326:0.010311:0.003024:0.009827:0.005125:0.005866:0.006380:0.012564:0.003024:0.005125:0.009223:0.006380:0.014182:0.009827:0.010326:0.003024:0.005866:0.004188:0.006380:0.009903:0.004551:0.006365:0.005866:0.009827:0.008376:0.009827:0.003024:0.010326:0.014182:0.009827:0.004551:0.005579:0.004188
and initially  use cholecalciferol 50  000  units weekly. If :@0.076196:0.376542:0.485136:0.376542:0.485136:0.360759:0.076196:0.360759:0.010326:0.009223:0.010357:0.006834:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.003024:0.008104:0.004188:0.002661:0.009192:0.005866:0.009827:0.006834:0.009782:0.009223:0.009903:0.003024:0.009827:0.009782:0.010326:0.003024:0.009782:0.003024:0.004747:0.009827:0.004551:0.009903:0.003024:0.006834:0.008376:0.008376:0.004188:0.002661:0.008376:0.008376:0.008376:0.004188:0.002661:0.009192:0.009223:0.003024:0.005125:0.005866:0.006834:0.012564:0.009827:0.009827:0.007590:0.003024:0.008104:0.004188:0.006834:0.003417:0.004747:0.004188
secondary hyperparathyroidism is not controlled, active :@0.076196:0.390881:0.485136:0.390881:0.485136:0.375098:0.076196:0.375098:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.010326:0.004551:0.008104:0.003477:0.009223:0.008104:0.010311:0.009827:0.004551:0.010311:0.010326:0.004551:0.010326:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.003492:0.003024:0.005866:0.003492:0.009223:0.009903:0.005125:0.003477:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003024:0.009827:0.010357:0.004188:0.003477:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.004188
vitamin D can be used (alfacalcidol at an initial dose of :@0.076196:0.405220:0.485151:0.405220:0.485151:0.389438:0.076196:0.389438:0.008376:0.003024:0.005125:0.010326:0.014182:0.003024:0.009223:0.003991:0.011249:0.003991:0.009782:0.010326:0.009223:0.003991:0.010311:0.009827:0.003991:0.009192:0.005866:0.009827:0.010357:0.003991:0.005579:0.010326:0.003024:0.004747:0.010326:0.009782:0.010326:0.003024:0.009782:0.003024:0.010357:0.009903:0.003024:0.004007:0.010326:0.005125:0.003991:0.010326:0.009223:0.003991:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.003991:0.010357:0.009903:0.005866:0.009827:0.003991:0.009903:0.004747:0.004188
0.25 µgm) and in severe cases a calcimimetic (cinacal-:@0.076196:0.419560:0.480963:0.419560:0.480963:0.403777:0.076196:0.403777:0.008376:0.004188:0.008376:0.008376:0.004158:0.008709:0.010175:0.014182:0.005579:0.004143:0.010326:0.009223:0.010357:0.004143:0.003024:0.009223:0.004143:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.004143:0.009782:0.010326:0.005866:0.009827:0.005866:0.004143:0.010326:0.004143:0.009782:0.010326:0.003024:0.009782:0.003024:0.014182:0.003024:0.014182:0.009827:0.005125:0.003024:0.009782:0.004158:0.005579:0.009782:0.003024:0.009223:0.010326:0.009782:0.010326:0.003069:0.005020
cet at an initial dose of 30 mg daily). parathyroidectomy :@0.076196:0.433899:0.485151:0.433899:0.485151:0.418117:0.076196:0.418117:0.009782:0.009827:0.005125:0.003387:0.010326:0.005125:0.003402:0.010326:0.009223:0.003402:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.003402:0.010357:0.009903:0.005866:0.009827:0.003402:0.009903:0.004747:0.003387:0.008376:0.008376:0.003402:0.014182:0.010175:0.003402:0.010357:0.010326:0.003024:0.003024:0.008104:0.005579:0.004188:0.003402:0.008950:0.010326:0.004551:0.010326:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.009827:0.009782:0.005125:0.009903:0.014182:0.008104:0.004188
must also be considered in the late phases where the :@0.076196:0.448239:0.485136:0.448239:0.485136:0.432456:0.076196:0.432456:0.014182:0.009192:0.005866:0.005125:0.005791:0.010326:0.003024:0.005866:0.009903:0.005791:0.010311:0.009827:0.005791:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.005791:0.003024:0.009223:0.005791:0.005125:0.009223:0.009827:0.005791:0.003024:0.010326:0.005125:0.009827:0.005791:0.010311:0.009223:0.010326:0.005866:0.009827:0.005866:0.005791:0.012564:0.009223:0.009827:0.004551:0.009827:0.005775:0.005125:0.009223:0.009827:0.004188
glands are autonomous, and both calcium and phos-:@0.076196:0.462578:0.480963:0.462578:0.480963:0.446796:0.076196:0.446796:0.010175:0.003024:0.010326:0.009223:0.010357:0.005866:0.005730:0.010326:0.004551:0.009827:0.005730:0.010326:0.009192:0.005125:0.009903:0.009223:0.009903:0.014182:0.009903:0.009192:0.005866:0.004188:0.005715:0.010326:0.009223:0.010357:0.005730:0.010311:0.009903:0.005125:0.009223:0.005715:0.009782:0.010326:0.003024:0.009782:0.003024:0.009192:0.014182:0.005730:0.010326:0.009223:0.010357:0.005730:0.010311:0.009223:0.009903:0.005866:0.005020
phate are elevated. There is a high risk of vascular cal-:@0.076196:0.476918:0.480963:0.476918:0.480963:0.461135:0.076196:0.461135:0.010311:0.009223:0.010326:0.005125:0.009827:0.004838:0.010326:0.004551:0.009827:0.004838:0.009827:0.003024:0.009827:0.008376:0.010326:0.005125:0.009827:0.010357:0.004188:0.004838:0.006441:0.009223:0.009827:0.004551:0.009827:0.004823:0.003024:0.005866:0.004838:0.010326:0.004838:0.009223:0.003024:0.010175:0.009223:0.004838:0.004551:0.003024:0.005866:0.007590:0.004838:0.009903:0.004747:0.004838:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004838:0.009782:0.010326:0.003024:0.005020
cification that may be fatal.:@0.076196:0.491257:0.280787:0.491257:0.280787:0.475475:0.076196:0.475475:0.009782:0.003024:0.003681:0.003681:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.005125:0.009223:0.010326:0.005125:0.004188:0.014182:0.010326:0.008104:0.004188:0.010311:0.009827:0.004188:0.004747:0.010326:0.005125:0.010326:0.003024:0.004188
Acidosis:@0.076190:0.522596:0.144058:0.522596:0.144058:0.504265:0.076190:0.504265:0.012431:0.010751:0.004032:0.011087:0.010751:0.007392:0.004032:0.007392
The kidney plays the principal role in the maintenance of :@0.076190:0.539102:0.485160:0.539102:0.485160:0.523320:0.076190:0.523320:0.006290:0.009071:0.009676:0.003825:0.007439:0.002873:0.010205:0.009071:0.009676:0.007953:0.003825:0.010160:0.002873:0.010175:0.007953:0.005715:0.003825:0.004974:0.009071:0.009676:0.003825:0.010160:0.004400:0.002873:0.009071:0.009631:0.002873:0.010160:0.010175:0.002873:0.003825:0.004400:0.009752:0.002873:0.009676:0.003825:0.002873:0.009071:0.003825:0.004974:0.009071:0.009676:0.003825:0.014030:0.010175:0.002873:0.009071:0.004974:0.009676:0.009071:0.010175:0.009071:0.009631:0.009676:0.003825:0.009752:0.004747:0.004188
acid-base balance, and in CKD stages 4 and 5 metabol-:@0.076190:0.553442:0.480927:0.553442:0.480927:0.537659:0.076190:0.537659:0.010175:0.009631:0.002873:0.010205:0.004868:0.010160:0.010175:0.005715:0.009676:0.003689:0.010160:0.010175:0.002873:0.010175:0.009071:0.009631:0.009676:0.004037:0.003689:0.010175:0.009071:0.010205:0.003689:0.002873:0.009071:0.003689:0.012141:0.008784:0.011097:0.003689:0.005715:0.004974:0.010175:0.010024:0.009676:0.005715:0.003689:0.008225:0.003689:0.010175:0.009071:0.010205:0.003689:0.008225:0.003689:0.014030:0.009676:0.004974:0.010175:0.010160:0.009752:0.002873:0.005020
ic acidosis may develop due to failure to excrete H  ions. :@0.076190:0.567781:0.485137:0.567770:0.485137:0.551988:0.076190:0.551999:0.002873:0.009631:0.003840:0.010175:0.009631:0.002873:0.010205:0.009752:0.005715:0.002873:0.005715:0.003840:0.014030:0.010175:0.007953:0.003840:0.010205:0.009676:0.008225:0.009676:0.002873:0.009752:0.010160:0.003840:0.010205:0.009041:0.009676:0.003840:0.004974:0.009752:0.003840:0.004596:0.010175:0.002873:0.002873:0.009041:0.004400:0.009676:0.003840:0.004974:0.009752:0.003840:0.009676:0.007106:0.009631:0.004400:0.009676:0.004974:0.009676:0.003840:0.010326:0.005117:0.003840:0.002873:0.009752:0.009071:0.005715:0.004188:0.105734
+:@0.440284:0.562472:0.445598:0.562472:0.445598:0.553318:0.440284:0.553318:0.005314
The  acidosis  can  be  associated  with  muscle-wasting, :@0.076197:0.582110:0.485092:0.582110:0.485092:0.566327:0.076197:0.566327:0.006290:0.009071:0.009676:0.004188:0.004233:0.010175:0.009631:0.002873:0.010205:0.009752:0.005715:0.002873:0.005715:0.004188:0.004233:0.009631:0.010175:0.009071:0.004188:0.004233:0.010160:0.009676:0.004188:0.004233:0.010175:0.005715:0.005715:0.009752:0.009631:0.002873:0.010175:0.004974:0.009676:0.010205:0.004188:0.004233:0.012413:0.002873:0.004974:0.009071:0.004188:0.004233:0.014030:0.009041:0.005715:0.009631:0.002873:0.009676:0.004868:0.012413:0.010175:0.005715:0.004974:0.002873:0.009071:0.010024:0.004188:0.004188
bone  disease,  hypo-albuminaemia,  inflammation,  the :@0.076197:0.596449:0.485122:0.596449:0.485122:0.580667:0.076197:0.580667:0.010160:0.009752:0.009071:0.009676:0.004188:0.004536:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004037:0.004188:0.004536:0.009071:0.007953:0.010160:0.009752:0.004868:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.010175:0.009676:0.014030:0.002873:0.010175:0.004037:0.004188:0.004536:0.002873:0.009071:0.003591:0.003591:0.010175:0.014030:0.014030:0.010175:0.004974:0.002873:0.009752:0.009071:0.004037:0.004188:0.004536:0.004974:0.009071:0.009827:0.004188
progression of CKD, and increased mortality. Adminis-:@0.076197:0.610789:0.480964:0.610789:0.480964:0.595006:0.076197:0.595006:0.010160:0.004400:0.009752:0.010024:0.004400:0.009676:0.005715:0.005715:0.002873:0.009752:0.009071:0.007514:0.009752:0.004596:0.007514:0.012141:0.008784:0.011097:0.004037:0.007514:0.010175:0.009071:0.010205:0.007514:0.002873:0.009071:0.009631:0.004400:0.009676:0.010175:0.005715:0.009676:0.010205:0.007514:0.014030:0.009752:0.004400:0.004974:0.010175:0.002873:0.002873:0.004974:0.007953:0.004037:0.007514:0.011037:0.010205:0.014030:0.002873:0.009071:0.002873:0.005715:0.005020
tration of Na  bicarbonate, if bicarbonate concentration :@0.076197:0.625128:0.485138:0.625106:0.485138:0.609324:0.076197:0.609345:0.004974:0.004400:0.010175:0.004974:0.002873:0.009752:0.009071:0.003492:0.009752:0.004596:0.003492:0.011037:0.010326:0.005066:0.003492:0.010160:0.002873:0.009631:0.010175:0.004400:0.010160:0.009752:0.009071:0.010175:0.004974:0.009676:0.004037:0.003492:0.002873:0.004596:0.003492:0.010160:0.002873:0.009631:0.010175:0.004400:0.010160:0.009752:0.009071:0.010175:0.004974:0.009676:0.003492:0.009631:0.009752:0.009071:0.009631:0.009676:0.009071:0.004974:0.004400:0.010175:0.004974:0.002873:0.009752:0.009223:0.030650
+:@0.164952:0.619808:0.170266:0.619808:0.170266:0.610654:0.164952:0.610654:0.005314
is <22 mmol/L, may decrease muscle-wasting, improve :@0.076183:0.639446:0.485138:0.639446:0.485138:0.623663:0.076183:0.623663:0.002873:0.005715:0.006169:0.009011:0.008225:0.008225:0.006169:0.014030:0.014030:0.009752:0.002873:0.006456:0.006834:0.004037:0.006169:0.014030:0.010175:0.007953:0.006169:0.010205:0.009676:0.009631:0.004400:0.009676:0.010175:0.005715:0.009676:0.006169:0.014030:0.009041:0.005715:0.009631:0.002873:0.009676:0.004868:0.012413:0.010175:0.005715:0.004974:0.002873:0.009071:0.010024:0.004037:0.006169:0.002873:0.014030:0.010160:0.004400:0.009752:0.008225:0.009827:0.004188
bone disease, and slow the progression of CKD. How-:@0.076183:0.653785:0.480935:0.653785:0.480935:0.638003:0.076183:0.638003:0.010160:0.009752:0.009071:0.009676:0.006849:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004037:0.006849:0.010175:0.009071:0.010205:0.006849:0.005715:0.002873:0.009752:0.012413:0.006849:0.004974:0.009071:0.009676:0.006849:0.010160:0.004400:0.009752:0.010024:0.004400:0.009676:0.005715:0.005715:0.002873:0.009752:0.009071:0.006849:0.009752:0.004596:0.006849:0.012141:0.008784:0.011097:0.004037:0.006849:0.010175:0.009752:0.012413:0.005020
ever, if the serum bicarbonate concentration exceeds :@0.076183:0.668125:0.485199:0.668125:0.485199:0.652342:0.076183:0.652342:0.009676:0.008225:0.009676:0.004400:0.004037:0.006471:0.002873:0.004596:0.006471:0.004974:0.009071:0.009676:0.006471:0.005715:0.009676:0.004400:0.009041:0.014030:0.006471:0.010160:0.002873:0.009631:0.010175:0.004400:0.010160:0.009752:0.009071:0.010175:0.004974:0.009676:0.006471:0.009631:0.009752:0.009071:0.009631:0.009676:0.009071:0.004974:0.004400:0.010175:0.004974:0.002873:0.009752:0.009071:0.006471:0.009676:0.007106:0.009631:0.009676:0.009676:0.010205:0.005866:0.004188
24 mmol/L, this might be associated with the exacerba-:@0.076183:0.682464:0.480980:0.682464:0.480980:0.666682:0.076183:0.666682:0.008225:0.008225:0.004868:0.014030:0.014030:0.009752:0.002873:0.006456:0.006834:0.004037:0.004868:0.004974:0.009071:0.002873:0.005715:0.004853:0.014030:0.002873:0.010024:0.009071:0.004974:0.004868:0.010160:0.009676:0.004868:0.010175:0.005715:0.005715:0.009752:0.009631:0.002873:0.010175:0.004974:0.009676:0.010205:0.004868:0.012413:0.002873:0.004974:0.009071:0.004868:0.004974:0.009071:0.009676:0.004868:0.009676:0.007106:0.010175:0.009631:0.009676:0.004400:0.010160:0.010175:0.005020
tion of cardiovascular disease. If acidosis is corrected, it :@0.076183:0.696804:0.485138:0.696804:0.485138:0.681021:0.076183:0.681021:0.004974:0.002873:0.009752:0.009071:0.005080:0.009752:0.004596:0.005080:0.009631:0.010175:0.004400:0.010205:0.002873:0.009752:0.008225:0.010175:0.005715:0.009631:0.009041:0.002873:0.010175:0.004400:0.005080:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004037:0.005080:0.003266:0.004596:0.005080:0.010175:0.009631:0.002873:0.010205:0.009752:0.005715:0.002873:0.005715:0.005080:0.002873:0.005715:0.005080:0.009631:0.009752:0.004400:0.004400:0.009676:0.009631:0.004974:0.009676:0.010205:0.004037:0.005080:0.002873:0.005125:0.004188
must be done cautiously with careful monitoring.:@0.076183:0.711143:0.425463:0.711143:0.425463:0.695360:0.076183:0.695360:0.014030:0.009041:0.005715:0.004974:0.004037:0.010160:0.009676:0.004037:0.010205:0.009752:0.009071:0.009676:0.004037:0.009631:0.010175:0.009041:0.004974:0.002873:0.009752:0.009041:0.005715:0.002873:0.007953:0.004037:0.012413:0.002873:0.004974:0.009071:0.004037:0.009631:0.010175:0.004400:0.009676:0.004596:0.009041:0.002873:0.004037:0.014030:0.009752:0.009071:0.002873:0.004974:0.009752:0.004400:0.002873:0.009071:0.010024:0.004188
Drugs and the kidney:@0.076190:0.742515:0.249555:0.742515:0.249555:0.724183:0.076190:0.724183:0.011759:0.005376:0.010079:0.011087:0.007392:0.004704:0.011087:0.010079:0.011087:0.004704:0.005040:0.010079:0.010751:0.004704:0.009743:0.004032:0.011087:0.010079:0.010751:0.009743
The kidney excretes many drugs, and if a drug and its :@0.076190:0.759021:0.485115:0.759021:0.485115:0.743238:0.076190:0.743238:0.006441:0.009223:0.009827:0.005670:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.005670:0.009827:0.007257:0.009782:0.004551:0.009827:0.005125:0.009827:0.005866:0.005670:0.014182:0.010326:0.009223:0.008104:0.005670:0.010357:0.004551:0.009192:0.010175:0.005866:0.004188:0.005670:0.010326:0.009223:0.010357:0.005670:0.003024:0.004747:0.005670:0.010326:0.005670:0.010357:0.004551:0.009192:0.010175:0.005670:0.010326:0.009223:0.010357:0.005670:0.003024:0.005125:0.005866:0.004188
metabolites  are  excreted  by  the  kidney,  dose  modifi:@0.076190:0.773360:0.475923:0.773360:0.475923:0.757578:0.076190:0.757578:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.005125:0.009827:0.005866:0.004188:0.002419:0.010326:0.004551:0.009827:0.004188:0.002419:0.009827:0.007257:0.009782:0.004551:0.009827:0.005125:0.009827:0.010357:0.004188:0.002419:0.010311:0.008104:0.004188:0.002419:0.005125:0.009223:0.009827:0.004188:0.002419:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.004188:0.004188:0.002419:0.010357:0.009903:0.005866:0.009827:0.004188:0.002419:0.014182:0.009903:0.010357:0.003024:0.003681:0.003681
-:@0.475923:0.773360:0.480942:0.773360:0.480942:0.757578:0.475923:0.757578:0.005020
cation needs to be undertaken, based on the stage of :@0.076190:0.787700:0.485145:0.787700:0.485145:0.771917:0.076190:0.771917:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004642:0.009223:0.009827:0.009827:0.010357:0.005866:0.004642:0.005125:0.009903:0.004642:0.010311:0.009827:0.004642:0.009192:0.009223:0.010357:0.009827:0.004551:0.005125:0.010326:0.007590:0.009812:0.009223:0.004188:0.004642:0.010311:0.010326:0.005866:0.009827:0.010357:0.004642:0.009903:0.009223:0.004626:0.005125:0.009223:0.009827:0.004626:0.005866:0.005125:0.010326:0.010175:0.009827:0.004642:0.009903:0.004747:0.004188
CKD. This is especially important for drugs with a narrow :@0.076190:0.802039:0.485160:0.802039:0.485160:0.786256:0.076190:0.786256:0.012292:0.008935:0.011249:0.004188:0.004339:0.006441:0.009223:0.003024:0.005866:0.004339:0.003024:0.005866:0.004339:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004354:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.005125:0.004339:0.004747:0.009903:0.004551:0.004339:0.010357:0.004551:0.009192:0.010175:0.005866:0.004339:0.012564:0.003024:0.005125:0.009223:0.004339:0.010326:0.004339:0.009223:0.010326:0.004551:0.004551:0.009903:0.012564:0.004188
therapeutic/toxic index. Monitoring of drug levels may :@0.076190:0.816379:0.485130:0.816379:0.485130:0.800596:0.076190:0.800596:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.009827:0.009192:0.005125:0.003024:0.009782:0.006607:0.005125:0.009903:0.007257:0.003024:0.009782:0.005549:0.003024:0.009223:0.010357:0.009827:0.007257:0.004188:0.005564:0.013894:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.003024:0.009223:0.010175:0.005549:0.009903:0.004747:0.005564:0.010357:0.004551:0.009192:0.010175:0.005549:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.005564:0.014182:0.010326:0.008104:0.004188
be necessary (e.g.  aminoglycosides, lithium).  patients :@0.076190:0.830718:0.485145:0.830718:0.485145:0.814935:0.076190:0.814935:0.010311:0.009827:0.007302:0.009223:0.009827:0.009782:0.009827:0.005866:0.005866:0.010326:0.004551:0.008104:0.007302:0.005579:0.009827:0.004188:0.010175:0.004188:0.004188:0.003099:0.010326:0.014182:0.003024:0.009223:0.009903:0.010175:0.003024:0.008104:0.009782:0.009903:0.005866:0.003024:0.010357:0.009827:0.005866:0.004188:0.007302:0.003024:0.003024:0.005125:0.009223:0.003024:0.009192:0.014182:0.005579:0.004188:0.004188:0.003115:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188
should avoid  nephrotoxic  drugs wherever possible. :@0.076190:0.845057:0.485130:0.845057:0.485130:0.829275:0.076190:0.829275:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.011173:0.010326:0.008376:0.009903:0.003024:0.010357:0.004188:0.007000:0.009223:0.009827:0.010311:0.009223:0.004551:0.009903:0.005125:0.009903:0.007257:0.003024:0.009782:0.004188:0.006970:0.010357:0.004551:0.009192:0.010175:0.005866:0.011173:0.012564:0.009223:0.009827:0.004551:0.009827:0.008376:0.009827:0.004551:0.011173:0.010311:0.009903:0.005866:0.005866:0.003024:0.010311:0.003024:0.009827:0.004188:0.004188
NSAIDs are a significant problem, causing progression of :@0.076190:0.859397:0.485145:0.859397:0.485145:0.843614:0.076190:0.843614:0.011188:0.007529:0.011188:0.003417:0.011249:0.005866:0.003492:0.010326:0.004551:0.009827:0.003492:0.010326:0.003492:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.003492:0.010311:0.004551:0.009903:0.010311:0.003024:0.009827:0.014182:0.004188:0.003492:0.009782:0.010326:0.009192:0.005866:0.003024:0.009223:0.010175:0.003492:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.003477:0.009903:0.004747:0.004188
CKD, the increase of salt and water excretion resulting :@0.076190:0.873736:0.485145:0.873736:0.485145:0.857954:0.076190:0.857954:0.012292:0.008935:0.011249:0.004188:0.005216:0.005125:0.009223:0.009827:0.005201:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005216:0.009903:0.004747:0.005216:0.005866:0.010326:0.003024:0.005125:0.005216:0.010326:0.009223:0.010357:0.005216:0.012564:0.010326:0.005125:0.009827:0.004551:0.005201:0.009827:0.007257:0.009782:0.004551:0.009827:0.005125:0.003024:0.009903:0.009223:0.005201:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.003024:0.009223:0.010175:0.004188
in uncontrolled Bp and risk of heart failure, and danger-:@0.076190:0.888076:0.480972:0.888076:0.480972:0.872293:0.076190:0.872293:0.003024:0.009223:0.004324:0.009192:0.009223:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003024:0.009827:0.010357:0.004309:0.008678:0.008950:0.004324:0.010326:0.009223:0.010357:0.004324:0.004551:0.003024:0.005866:0.007590:0.004324:0.009903:0.004747:0.004309:0.009223:0.009827:0.010326:0.004551:0.005125:0.004309:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.004324:0.010326:0.009223:0.010357:0.004324:0.010357:0.010326:0.009223:0.010175:0.009827:0.004551:0.005020
ously high K  levels. Over-the-counter  herbal medica-:@0.076190:0.902415:0.480941:0.902361:0.480941:0.886578:0.076190:0.886633:0.009903:0.009192:0.005866:0.003024:0.008104:0.006864:0.009223:0.003024:0.010175:0.009223:0.006864:0.008935:0.005305:0.006864:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.004188:0.006864:0.013138:0.008376:0.009827:0.004551:0.005020:0.005125:0.009223:0.009827:0.005020:0.009782:0.009903:0.009192:0.009223:0.005125:0.009827:0.004551:0.004188:0.002661:0.009223:0.009827:0.004536:0.010311:0.010326:0.003024:0.006864:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:-0.327393
+:@0.166579:0.897062:0.171893:0.897062:0.171893:0.887908:0.166579:0.887908:0.005314
tions should be avoided as they often contain multiple, :@0.076189:0.916700:0.485129:0.916700:0.485129:0.900918:0.076189:0.900918:0.005125:0.003024:0.009903:0.009223:0.005866:0.004490:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004490:0.010311:0.009827:0.004490:0.010326:0.008376:0.009903:0.003024:0.010357:0.009827:0.010357:0.004505:0.010326:0.005866:0.004490:0.005125:0.009223:0.009827:0.008104:0.004490:0.009903:0.004747:0.005125:0.009827:0.009223:0.004490:0.009782:0.009903:0.009223:0.005125:0.010326:0.003024:0.009223:0.004490:0.014182:0.009192:0.003024:0.005125:0.003024:0.010311:0.003024:0.009827:0.004188:0.004188
active components with unknown pharmacokinetic :@0.076189:0.931040:0.485144:0.931040:0.485144:0.915257:0.076189:0.915257:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.010477:0.009782:0.009903:0.014182:0.010311:0.009903:0.009223:0.009827:0.009223:0.005125:0.005866:0.010477:0.012564:0.003024:0.005125:0.009223:0.010477:0.009192:0.009223:0.007590:0.009223:0.009903:0.012564:0.009223:0.010477:0.010311:0.009223:0.010326:0.004551:0.014182:0.010326:0.009782:0.009903:0.007590:0.003024:0.009223:0.009827:0.005125:0.003024:0.009782:0.004188
data or toxicity studies.:@0.076189:0.945379:0.244131:0.945379:0.244131:0.929596:0.076189:0.929596:0.010357:0.010326:0.005125:0.010326:0.004188:0.009903:0.004551:0.004188:0.005125:0.009903:0.007257:0.003024:0.009782:0.003024:0.005125:0.008104:0.004188:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.004188
Depression:@0.519047:0.086287:0.608417:0.086287:0.608417:0.067956:0.519047:0.067956:0.011759:0.010751:0.011087:0.005376:0.010751:0.007392:0.007392:0.004032:0.010751:0.010079
Mental illness, especially depression, is common in pa-:@0.519047:0.102537:0.923799:0.102537:0.923799:0.086755:0.519047:0.086755:0.013894:0.009827:0.009223:0.005125:0.010326:0.003024:0.005609:0.003024:0.003024:0.003024:0.009223:0.009827:0.005866:0.005866:0.004188:0.005609:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.005624:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.005609:0.003024:0.005866:0.005609:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.005594:0.003024:0.009223:0.005609:0.010311:0.010326:0.005020
tients with CKD, and this should be assessed from time to :@0.519047:0.116611:0.928017:0.116611:0.928017:0.100828:0.519047:0.100828:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003477:0.012564:0.003024:0.005125:0.009223:0.003477:0.012292:0.008935:0.011249:0.004188:0.003477:0.010326:0.009223:0.010357:0.003477:0.005125:0.009223:0.003024:0.005866:0.003477:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003477:0.010311:0.009827:0.003477:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.009827:0.010357:0.003492:0.004747:0.004551:0.009903:0.014182:0.003462:0.005125:0.003024:0.014182:0.009827:0.003477:0.005125:0.009903:0.004188
time, and appropriate treatment instituted.:@0.519047:0.130685:0.834007:0.130685:0.834007:0.114902:0.519047:0.114902:0.005125:0.003024:0.014182:0.009827:0.004188:0.004188:0.010326:0.009223:0.010357:0.004188:0.010326:0.010311:0.010311:0.004551:0.009903:0.010311:0.004551:0.003024:0.010326:0.005125:0.009827:0.004188:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003024:0.009223:0.005866:0.005125:0.003024:0.005125:0.009192:0.005125:0.009827:0.010357:0.004188
PrePArAtiOn fOr DiAlysis:@0.519047:0.163519:0.761489:0.163519:0.761489:0.143354:0.519047:0.143354:0.010348:0.010718:0.009609:0.010348:0.013674:0.010718:0.013674:0.007761:0.005174:0.015522:0.013674:0.005174:0.008870:0.015522:0.010718:0.005174:0.012935:0.005174:0.013674:0.008131:0.011457:0.009609:0.005174:0.009609
AnD trAnsPlAntAtiOn:@0.519047:0.180156:0.729336:0.180156:0.729336:0.159991:0.519047:0.159991:0.013674:0.013674:0.012935:0.005174:0.007761:0.010718:0.013674:0.013674:0.009609:0.010348:0.008131:0.013674:0.013674:0.007761:0.013674:0.007761:0.005174:0.015522:0.013674
It  is crucial that  patients  with  advanced CKD  be  re-:@0.519047:0.196019:0.923799:0.196019:0.923799:0.180236:0.519047:0.180236:0.003417:0.005125:0.004188:0.003417:0.003024:0.005866:0.007620:0.009782:0.004551:0.009192:0.009782:0.003024:0.010326:0.003024:0.007620:0.005125:0.009223:0.010326:0.005125:0.004188:0.003417:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.003417:0.012564:0.003024:0.005125:0.009223:0.004188:0.003417:0.010326:0.010357:0.008376:0.010326:0.009223:0.009782:0.009827:0.010357:0.007620:0.012292:0.008935:0.011249:0.004188:0.003417:0.010311:0.009827:0.004188:0.003417:0.004551:0.009827:0.005020
ferred to a nephrologist before reaching the end stage. :@0.519047:0.210093:0.927972:0.210093:0.927972:0.194310:0.519047:0.194310:0.004747:0.009827:0.004551:0.004551:0.009827:0.010357:0.003870:0.005125:0.009903:0.003870:0.010326:0.003886:0.009223:0.009827:0.010311:0.009223:0.004551:0.009903:0.003024:0.009903:0.010175:0.003024:0.005866:0.005125:0.003870:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.003870:0.004551:0.009827:0.010326:0.009782:0.009223:0.003024:0.009223:0.010175:0.003870:0.005125:0.009223:0.009827:0.003870:0.009827:0.009223:0.010357:0.003870:0.005866:0.005125:0.010326:0.010175:0.009827:0.004188:0.004188
This should ideally occur at CKD stage 3b, but is man-:@0.519047:0.224167:0.923784:0.224167:0.923784:0.208384:0.519047:0.208384:0.006441:0.009223:0.003024:0.005866:0.005730:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005730:0.003024:0.010357:0.009827:0.010326:0.003024:0.003024:0.008104:0.005745:0.009903:0.009782:0.009782:0.009192:0.004551:0.005730:0.010326:0.005125:0.005730:0.012292:0.008935:0.011249:0.005730:0.005866:0.005125:0.010326:0.010175:0.009827:0.005730:0.008376:0.010311:0.004188:0.005730:0.010311:0.009192:0.005125:0.005730:0.003024:0.005866:0.005745:0.014182:0.010326:0.009223:0.005020
datory at stage 4.  patients presenting with end-stage :@0.519047:0.238240:0.928017:0.238240:0.928017:0.222458:0.519047:0.222458:0.010357:0.010326:0.005125:0.009903:0.004551:0.008104:0.006683:0.010326:0.005125:0.006683:0.005866:0.005125:0.010326:0.010175:0.009827:0.006683:0.008376:0.004188:0.004188:0.002495:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006683:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.003024:0.009223:0.010175:0.006683:0.012564:0.003024:0.005125:0.009223:0.006683:0.009827:0.009223:0.010357:0.005020:0.005866:0.005125:0.010326:0.010175:0.009827:0.004188
CKD requiring urgent dialysis have a poorer prognosis, :@0.519047:0.252314:0.928017:0.252314:0.928017:0.236532:0.519047:0.236532:0.012292:0.008935:0.011249:0.005806:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.003024:0.009223:0.010175:0.005791:0.009192:0.004551:0.010175:0.009827:0.009223:0.005125:0.005791:0.010357:0.003024:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.005821:0.009223:0.010326:0.008376:0.009827:0.005806:0.010326:0.005806:0.010311:0.009903:0.009903:0.004551:0.009827:0.004551:0.005791:0.010311:0.004551:0.009903:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188
with excess mortality in the first year. Early referral often :@0.519047:0.266388:0.928017:0.266388:0.928017:0.250606:0.519047:0.250606:0.012564:0.003024:0.005125:0.009223:0.004717:0.009827:0.007257:0.009782:0.009827:0.005866:0.005866:0.004717:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004717:0.003024:0.009223:0.004717:0.005125:0.009223:0.009827:0.004702:0.003681:0.003681:0.004551:0.005866:0.005125:0.004702:0.008104:0.009827:0.010326:0.004551:0.004188:0.004702:0.008104:0.010326:0.004551:0.003024:0.008104:0.004717:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.010326:0.003024:0.004702:0.009903:0.004747:0.005125:0.009827:0.009223:0.004188
leads to delayed progression of CKD and enables plan-:@0.519047:0.280462:0.923814:0.280462:0.923814:0.264680:0.519047:0.264680:0.003024:0.009827:0.010326:0.010357:0.005866:0.004007:0.005125:0.009903:0.003991:0.010357:0.009827:0.003024:0.010326:0.008104:0.009827:0.010357:0.004007:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.003991:0.009903:0.004747:0.003991:0.012292:0.008935:0.011249:0.003991:0.010326:0.009223:0.010357:0.003991:0.009827:0.009223:0.010326:0.010311:0.003024:0.009827:0.005866:0.004007:0.010311:0.003024:0.010326:0.009223:0.005020
ning – for example, the timeous insertion of a Tenchkoff :@0.519047:0.294536:0.928017:0.294536:0.928017:0.278753:0.519047:0.278753:0.009223:0.003024:0.009223:0.010175:0.004430:0.007560:0.004430:0.004747:0.009903:0.004551:0.004430:0.009827:0.007257:0.010326:0.014182:0.010311:0.003024:0.009827:0.004188:0.004445:0.005125:0.009223:0.009827:0.004430:0.005125:0.003024:0.014182:0.009827:0.009903:0.009192:0.005866:0.004445:0.003024:0.009223:0.005866:0.009827:0.004551:0.005125:0.003024:0.009903:0.009223:0.004430:0.009903:0.004747:0.004430:0.010326:0.004445:0.006441:0.009827:0.009223:0.009782:0.009223:0.007590:0.009903:0.004747:0.004747:0.004188
catheter for peritoneal dialysis or the creation of an A-V :@0.519047:0.308610:0.928017:0.308610:0.928017:0.292827:0.519047:0.292827:0.009782:0.010326:0.005125:0.009223:0.009827:0.005125:0.009827:0.004551:0.003946:0.004747:0.009903:0.004551:0.003961:0.010311:0.009827:0.004551:0.003024:0.005125:0.009903:0.009223:0.009827:0.010326:0.003024:0.003961:0.010357:0.003024:0.010326:0.003024:0.008104:0.005866:0.003024:0.005881:0.003961:0.009903:0.004551:0.003961:0.005125:0.009223:0.009827:0.003961:0.009782:0.004551:0.009827:0.010326:0.005125:0.003024:0.009903:0.009223:0.003961:0.009903:0.004747:0.003961:0.010326:0.009223:0.003961:0.011188:0.005020:0.010614:0.004188
fistula for haemodialysis. In some circumstances, a pre-:@0.519047:0.322684:0.923829:0.322684:0.923829:0.306901:0.519047:0.306901:0.003681:0.003681:0.005866:0.005125:0.009192:0.003024:0.010326:0.004899:0.004747:0.009903:0.004551:0.004883:0.009223:0.010326:0.009827:0.014182:0.009903:0.010357:0.003024:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.004188:0.004914:0.003417:0.009223:0.004899:0.005866:0.009903:0.014182:0.009827:0.004899:0.009782:0.003024:0.004551:0.009782:0.009192:0.014182:0.005866:0.005125:0.010326:0.009223:0.009782:0.009827:0.005866:0.004188:0.004883:0.010326:0.004899:0.010311:0.004551:0.009827:0.005020
emptive live-related or live-unrelated transplant can :@0.519047:0.336758:0.927972:0.336758:0.927972:0.320975:0.519047:0.320975:0.009827:0.014182:0.010311:0.005125:0.003024:0.008376:0.009827:0.008830:0.003024:0.003024:0.008376:0.009827:0.005020:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.008830:0.009903:0.004551:0.008830:0.003024:0.003024:0.008376:0.009827:0.005020:0.009192:0.009223:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.008830:0.005125:0.004551:0.010326:0.009223:0.005866:0.010311:0.003024:0.010326:0.009223:0.005125:0.008830:0.009782:0.010326:0.009223:0.004188
be performed before starting dialysis. In the frail elderly, :@0.519047:0.350832:0.927987:0.350832:0.927987:0.335049:0.519047:0.335049:0.010311:0.009827:0.004324:0.010311:0.009827:0.004551:0.004747:0.009903:0.004551:0.014182:0.009827:0.010357:0.004324:0.010311:0.009827:0.004747:0.009903:0.004551:0.009827:0.004324:0.005866:0.005125:0.010326:0.004551:0.005125:0.003024:0.009223:0.010175:0.004324:0.010357:0.003024:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.004188:0.004339:0.003417:0.009223:0.004324:0.005125:0.009223:0.009827:0.004324:0.004747:0.004551:0.010326:0.003024:0.003024:0.004324:0.009827:0.003024:0.010357:0.009827:0.004551:0.003024:0.008104:0.004188:0.004188
conservative treatment  may be strongly considered :@0.519047:0.364906:0.927987:0.364906:0.927987:0.349123:0.519047:0.349123:0.009782:0.009903:0.009223:0.005866:0.009827:0.004551:0.008376:0.010326:0.005125:0.003024:0.008376:0.009827:0.009162:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.004959:0.014182:0.010326:0.008104:0.009162:0.010311:0.009827:0.009162:0.005866:0.005125:0.004551:0.009903:0.009223:0.010175:0.003024:0.008104:0.009162:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.004188
as dialysis has not been shown to prolong life. All these :@0.519047:0.378979:0.927972:0.378979:0.927972:0.363197:0.519047:0.363197:0.010326:0.005866:0.004929:0.010357:0.003024:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.004944:0.009223:0.010326:0.005866:0.004929:0.009223:0.009903:0.005125:0.004929:0.010311:0.009827:0.009827:0.009223:0.004929:0.005866:0.009223:0.009903:0.012564:0.009223:0.004929:0.005125:0.009903:0.004929:0.010311:0.004551:0.009903:0.003024:0.009903:0.009223:0.010175:0.004914:0.003024:0.003024:0.004747:0.009827:0.004188:0.004929:0.011188:0.003024:0.003024:0.004929:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188
complex issues need to be discussed with the patient :@0.519047:0.393053:0.927987:0.393053:0.927987:0.377271:0.519047:0.377271:0.009782:0.009903:0.014182:0.010311:0.003024:0.009827:0.007257:0.006153:0.003024:0.005866:0.005866:0.009192:0.009827:0.005866:0.006153:0.009223:0.009827:0.009827:0.010357:0.006153:0.005125:0.009903:0.006138:0.010311:0.009827:0.006153:0.010357:0.003024:0.005866:0.009782:0.009192:0.005866:0.005866:0.009827:0.010357:0.006153:0.012564:0.003024:0.005125:0.009223:0.006153:0.005125:0.009223:0.009827:0.006153:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004188
and family so that an informed choice can be made. :@0.519047:0.407127:0.915060:0.407127:0.915060:0.391345:0.519047:0.391345:0.010326:0.009223:0.010357:0.004188:0.004747:0.010326:0.014182:0.003024:0.003024:0.008104:0.004188:0.005866:0.009903:0.004188:0.005125:0.009223:0.010326:0.005125:0.004188:0.010326:0.009223:0.004188:0.003024:0.009223:0.004747:0.009903:0.004551:0.014182:0.009827:0.010357:0.004188:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.004188:0.009782:0.010326:0.009223:0.004188:0.010311:0.009827:0.004188:0.014182:0.010326:0.010357:0.009827:0.004188:0.004188
COnClusiOn:@0.519047:0.438733:0.641007:0.438733:0.641007:0.418568:0.519047:0.418568:0.014413:0.015522:0.013674:0.014413:0.008131:0.011826:0.009609:0.005174:0.015522:0.013674
CKD is a common problem affecting about 10% of the :@0.519047:0.454589:0.927987:0.454589:0.927987:0.438807:0.519047:0.438807:0.012292:0.008935:0.011249:0.004959:0.003024:0.005866:0.004974:0.010326:0.004959:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004959:0.010311:0.004551:0.009903:0.010311:0.003024:0.009827:0.014182:0.004959:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.009223:0.010175:0.004959:0.010326:0.010311:0.009903:0.009192:0.005125:0.004959:0.008376:0.008376:0.011717:0.004959:0.009903:0.004747:0.004959:0.005125:0.009223:0.009827:0.004188
population. Early recognition and treatment can delay :@0.519047:0.468663:0.928002:0.468663:0.928002:0.452880:0.519047:0.452880:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004702:0.008104:0.010326:0.004551:0.003024:0.008104:0.004702:0.004551:0.009827:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.004687:0.010326:0.009223:0.010357:0.004702:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004687:0.009782:0.010326:0.009223:0.004702:0.010357:0.009827:0.003024:0.010326:0.008104:0.004188
and prevent the progression of the disease and adverse :@0.519047:0.482737:0.927972:0.482737:0.927972:0.466954:0.519047:0.466954:0.010326:0.009223:0.010357:0.003417:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003402:0.005125:0.009223:0.009827:0.003402:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.003402:0.009903:0.004747:0.003402:0.005125:0.009223:0.009827:0.003402:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.003417:0.010326:0.009223:0.010357:0.003417:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.004188
cardiovascular outcomes, which have significant impli:@0.519047:0.496811:0.918764:0.496811:0.918764:0.481028:0.519047:0.481028:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004823:0.009903:0.009192:0.005125:0.009782:0.009903:0.014182:0.009827:0.005866:0.004188:0.004808:0.012564:0.009223:0.003024:0.009782:0.009223:0.004823:0.009223:0.010326:0.008376:0.009827:0.004823:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.004823:0.003024:0.014182:0.010311:0.003024:0.003024
-:@0.918794:0.496811:0.923814:0.496811:0.923814:0.481028:0.918794:0.481028:0.005020
cations for the health of the individual and economic :@0.519047:0.510885:0.928002:0.510885:0.928002:0.495102:0.519047:0.495102:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.005896:0.004747:0.009903:0.004551:0.005881:0.005125:0.009223:0.009827:0.005881:0.009223:0.009827:0.010326:0.003024:0.005125:0.009223:0.005881:0.009903:0.004747:0.005881:0.005125:0.009223:0.009827:0.005881:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.005912:0.010326:0.009223:0.010357:0.005896:0.009827:0.009782:0.009903:0.009223:0.009903:0.014182:0.003024:0.009782:0.004188
implications for  healthcare  providers.  Detection  and :@0.519047:0.524959:0.927987:0.524959:0.927987:0.509176:0.519047:0.509176:0.003024:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.008724:0.004747:0.009903:0.004551:0.004188:0.004521:0.009223:0.009827:0.010326:0.003024:0.005125:0.009223:0.009782:0.010326:0.004551:0.009827:0.004188:0.004521:0.010311:0.004551:0.009903:0.008376:0.003024:0.010357:0.009827:0.004551:0.005866:0.004188:0.004188:0.004521:0.011249:0.009827:0.005125:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004521:0.010326:0.009223:0.010357:0.004188
prevention should be managed by primary care prac-:@0.519047:0.539033:0.923814:0.539033:0.923814:0.523250:0.519047:0.523250:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.005035:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005050:0.010311:0.009827:0.005050:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.010357:0.005050:0.010311:0.008104:0.005050:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.005050:0.009782:0.010326:0.004551:0.009827:0.005035:0.010311:0.004551:0.010326:0.009782:0.005020
titioners, but with advancing CKD, especially stages 3b :@0.519047:0.553106:0.927987:0.553106:0.927987:0.537324:0.519047:0.537324:0.005125:0.003024:0.005125:0.003024:0.009903:0.009223:0.009827:0.004551:0.005866:0.004188:0.004823:0.010311:0.009192:0.005125:0.004838:0.012564:0.003024:0.005125:0.009223:0.004838:0.010326:0.010357:0.008376:0.010326:0.009223:0.009782:0.003024:0.009223:0.010175:0.004838:0.012292:0.008935:0.011249:0.004188:0.004838:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004853:0.005866:0.005125:0.010326:0.010175:0.009827:0.005866:0.004838:0.008376:0.010311:0.004188
and beyond, management is increasingly complex and :@0.519047:0.567180:0.927987:0.567180:0.927987:0.551398:0.519047:0.551398:0.010326:0.009223:0.010357:0.003553:0.010311:0.009827:0.008104:0.009903:0.009223:0.010357:0.004188:0.003538:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.003538:0.003024:0.005866:0.003553:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.003024:0.009223:0.010175:0.003024:0.008104:0.003553:0.009782:0.009903:0.014182:0.010311:0.003024:0.009827:0.007257:0.003553:0.010326:0.009223:0.010357:0.004188
these patients need to be referred to nephrologists or :@0.519047:0.581254:0.928002:0.581254:0.928002:0.565472:0.519047:0.565472:0.005125:0.009223:0.009827:0.005866:0.009827:0.005987:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006002:0.009223:0.009827:0.009827:0.010357:0.005987:0.005125:0.009903:0.005987:0.010311:0.009827:0.006002:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.009827:0.010357:0.005987:0.005125:0.009903:0.005987:0.009223:0.009827:0.010311:0.009223:0.004551:0.009903:0.003024:0.009903:0.010175:0.003024:0.005866:0.005125:0.005866:0.005987:0.009903:0.004551:0.004188
specialist physicians.:@0.519047:0.595328:0.668348:0.595328:0.668348:0.579546:0.519047:0.579546:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.005866:0.005125:0.004188:0.010311:0.009223:0.008104:0.005866:0.003024:0.009782:0.003024:0.010326:0.009223:0.005866:0.004188
referenCes:@0.519047:0.628196:0.625485:0.628196:0.625485:0.608031:0.519047:0.608031:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1. :@0.519047:0.640057:0.532076:0.640057:0.532076:0.627782:0.519047:0.627782:0.006515:0.003257:0.003257
Mayosi BM, Fisher AJ, Lalloo UG, :@0.544247:0.640057:0.726763:0.640057:0.726763:0.627782:0.544247:0.627782:0.010807:0.008032:0.006303:0.007702:0.004563:0.002352:0.003069:0.006750:0.010807:0.003257:0.003057:0.005703:0.002352:0.004563:0.007173:0.007644:0.003540:0.003057:0.008702:0.005668:0.003257:0.003057:0.005433:0.008032:0.002352:0.002352:0.007702:0.007702:0.003057:0.007702:0.010254:0.003257:0.003257
et al.:@0.726563:0.640057:0.754891:0.640057:0.754891:0.627782:0.726563:0.627782:0.007644:0.003986:0.003057:0.008032:0.002352:0.003257
 The burden of non-communi-:@0.754891:0.640057:0.923812:0.640057:0.923812:0.627782:0.754891:0.627782:0.003057:0.005009:0.007173:0.007644:0.003057:0.008020:0.007150:0.003540:0.008055:0.007644:0.007173:0.003057:0.007702:0.003692:0.003057:0.007173:0.007702:0.007173:0.003904:0.007608:0.007702:0.011030:0.011030:0.007150:0.007173:0.002340:0.003904
cable diseases in south Africa. :@0.544247:0.650932:0.720177:0.650932:0.720177:0.638656:0.544247:0.638656:0.007608:0.008032:0.008020:0.002352:0.007644:0.003257:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.004563:0.003257:0.002352:0.007173:0.003257:0.005856:0.007702:0.007150:0.003986:0.007173:0.003257:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.003257:0.003257
Lancet.:@0.720166:0.650932:0.763299:0.650932:0.763299:0.638656:0.720166:0.638656:0.005433:0.008032:0.007173:0.007608:0.007644:0.003986:0.003257
 2009; 374: 934-947.:@0.763287:0.650932:0.871425:0.650932:0.871425:0.638656:0.763287:0.638656:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
2. :@0.519035:0.661806:0.532065:0.661806:0.532065:0.649531:0.519035:0.649531:0.006515:0.003257:0.003257
Ekrikpo UE, Kengne Ap, Bello AK, :@0.544235:0.661806:0.737793:0.661806:0.737793:0.649531:0.544235:0.649531:0.006303:0.005903:0.003540:0.002352:0.005903:0.008020:0.007702:0.004845:0.007702:0.006303:0.003257:0.004845:0.006950:0.007644:0.007173:0.007914:0.007173:0.007644:0.004833:0.008702:0.006961:0.003257:0.004833:0.006750:0.007644:0.002352:0.002352:0.007702:0.004845:0.008702:0.006950:0.003246:0.003257
et al.:@0.739380:0.661806:0.769496:0.661806:0.769496:0.649531:0.739380:0.649531:0.007644:0.003986:0.004845:0.008032:0.002352:0.003257
 Chronic kidney disease in :@0.769496:0.661806:0.927034:0.661806:0.927034:0.649531:0.769496:0.649531:0.004845:0.009560:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.004833:0.005903:0.002352:0.008055:0.007173:0.007644:0.006303:0.004845:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.004845:0.002352:0.007173:0.003257
the global adult HIV-infected population: a systematic review and :@0.544235:0.672681:0.927058:0.672681:0.927058:0.660405:0.544235:0.660405:0.003986:0.007173:0.007644:0.003645:0.007914:0.002352:0.007702:0.008020:0.008032:0.002352:0.003657:0.008032:0.008055:0.007150:0.002352:0.003986:0.003657:0.008032:0.002658:0.008255:0.003904:0.002352:0.007173:0.003692:0.007644:0.007608:0.003986:0.007644:0.008055:0.003657:0.008020:0.007702:0.008020:0.007150:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.003657:0.008032:0.003657:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.003657:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003657:0.008032:0.007173:0.008055:0.003257
meta-analysis. :@0.544235:0.683555:0.628714:0.683555:0.628714:0.671280:0.544235:0.671280:0.011030:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003257:0.003257
PLoS One:@0.628726:0.683555:0.682971:0.683555:0.682971:0.671280:0.628726:0.671280:0.006961:0.005433:0.007702:0.005856:0.003257:0.010219:0.007173:0.007644
. 2018;13(4):e0195443.:@0.682959:0.683555:0.806772:0.683555:0.806772:0.671280:0.682959:0.671280:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.007644:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
3. :@0.519035:0.694430:0.532065:0.694430:0.532065:0.682154:0.519035:0.682154:0.006515:0.003257:0.003257
Chronic  Kidney Disease  prognosis Consortium,  Matsushita K,  van :@0.544235:0.694430:0.927058:0.694430:0.927058:0.682154:0.544235:0.682154:0.009560:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.003257:0.002364:0.006950:0.002352:0.008055:0.007173:0.007644:0.006303:0.005633:0.008749:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.002375:0.006961:0.003540:0.007702:0.007914:0.007173:0.007702:0.004563:0.002340:0.004563:0.005633:0.009560:0.007702:0.007173:0.004563:0.007702:0.003540:0.003986:0.002352:0.007150:0.011030:0.003257:0.003257:0.002364:0.010807:0.008032:0.003986:0.004563:0.007150:0.004563:0.007173:0.002352:0.003986:0.008032:0.005633:0.006950:0.003257:0.003257:0.002364:0.006515:0.008032:0.007173:0.003257
der Velde M, Astor BC, :@0.544235:0.705304:0.680525:0.705304:0.680525:0.693029:0.544235:0.693029:0.008055:0.007644:0.003540:0.004433:0.008255:0.007644:0.002352:0.008055:0.007644:0.004433:0.010807:0.003257:0.004433:0.008702:0.004563:0.003986:0.007702:0.003528:0.004433:0.006750:0.009560:0.003257:0.003257
et al.:@0.681701:0.705304:0.711405:0.705304:0.711405:0.693029:0.681701:0.693029:0.007644:0.003986:0.004433:0.008032:0.002352:0.003257
 Association of estimated glomerular :@0.711405:0.705304:0.927070:0.705304:0.927070:0.693029:0.711405:0.693029:0.004433:0.008702:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.004433:0.007702:0.003692:0.004433:0.007644:0.004563:0.003986:0.002352:0.011030:0.008032:0.003986:0.007644:0.008055:0.004433:0.007914:0.002352:0.007702:0.011030:0.007644:0.003540:0.007150:0.002352:0.008032:0.003540:0.003257
filtration  rate  and  albuminuria  with  all-cause  and  cardiovascular :@0.544235:0.716179:0.927046:0.716179:0.927046:0.703904:0.544235:0.703904:0.002863:0.002863:0.002352:0.003986:0.003540:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.002140:0.003540:0.008032:0.003986:0.007644:0.003257:0.002140:0.008032:0.007173:0.008055:0.003257:0.002140:0.008032:0.002352:0.008020:0.007150:0.011030:0.002352:0.007173:0.007150:0.003540:0.002352:0.008032:0.003257:0.002152:0.009772:0.002352:0.003986:0.007173:0.003257:0.002140:0.008032:0.002352:0.002352:0.003904:0.007608:0.008032:0.007150:0.004563:0.007644:0.003257:0.002152:0.008032:0.007173:0.008055:0.003257:0.002140:0.007608:0.008032:0.003540:0.008055:0.002352:0.007702:0.006515:0.008032:0.004563:0.007608:0.007150:0.002352:0.008032:0.003540:0.003257
mortality in general population cohorts: A collaborative meta-anal-:@0.544235:0.727053:0.923801:0.727053:0.923801:0.714778:0.544235:0.714778:0.011030:0.007702:0.003540:0.003986:0.008032:0.002352:0.002352:0.003986:0.006303:0.002834:0.002352:0.007173:0.002834:0.007914:0.007644:0.007173:0.007644:0.003540:0.008032:0.002352:0.002822:0.008020:0.007702:0.008020:0.007150:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.002834:0.007608:0.007702:0.007173:0.007702:0.003540:0.003986:0.004563:0.003257:0.002822:0.008702:0.002834:0.007608:0.007702:0.002352:0.002352:0.008032:0.008020:0.007702:0.003540:0.008032:0.003986:0.002352:0.006515:0.007644:0.002834:0.011030:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.003904
ysis.:@0.544235:0.737928:0.565273:0.737928:0.565273:0.725653:0.544235:0.725653:0.006303:0.004563:0.002352:0.004563:0.003257
 Lancet:@0.565285:0.737928:0.608417:0.737928:0.608417:0.725653:0.565285:0.725653:0.003257:0.005433:0.008032:0.007173:0.007608:0.007644:0.003986
. 2010;375(9731):2073-81.:@0.608406:0.737928:0.748023:0.737928:0.748023:0.725653:0.608406:0.725653:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
4. :@0.519035:0.748802:0.532065:0.748802:0.532065:0.736527:0.519035:0.736527:0.006515:0.003257:0.003257
Levin A, stevens pE. summary of KDIGO 2012 CKD Guideline: Be-:@0.544235:0.748802:0.923789:0.748802:0.923789:0.736527:0.544235:0.736527:0.005433:0.007644:0.006515:0.002352:0.007173:0.004762:0.008702:0.003257:0.004751:0.005856:0.003986:0.007644:0.006515:0.007644:0.007173:0.004563:0.004762:0.006961:0.006303:0.003257:0.004751:0.005856:0.007150:0.011030:0.011030:0.008032:0.003540:0.006303:0.004751:0.007702:0.003692:0.004751:0.006950:0.008749:0.002658:0.010254:0.010219:0.004762:0.006515:0.006515:0.006515:0.006515:0.004762:0.009560:0.006950:0.008749:0.004751:0.010254:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.003257:0.004762:0.006750:0.007644:0.003904
hind the scenes need for guidance, and a framework for moving :@0.544235:0.759677:0.927058:0.759677:0.927058:0.747402:0.544235:0.747402:0.007173:0.002352:0.007173:0.008055:0.004245:0.003986:0.007173:0.007644:0.004245:0.004563:0.007608:0.007644:0.007173:0.007644:0.004563:0.004245:0.007173:0.007644:0.007644:0.008055:0.004245:0.003692:0.007702:0.003540:0.004233:0.007914:0.007150:0.002352:0.008055:0.008032:0.007173:0.007608:0.007644:0.003257:0.004245:0.008032:0.007173:0.008055:0.004245:0.008032:0.004245:0.003692:0.003540:0.008032:0.011030:0.007644:0.009772:0.007702:0.003540:0.005903:0.004233:0.003692:0.007702:0.003540:0.004233:0.011030:0.007702:0.006515:0.002352:0.007173:0.007914:0.003257
forward. :@0.544235:0.770552:0.595082:0.770552:0.595082:0.758276:0.544235:0.758276:0.003692:0.007702:0.003540:0.009772:0.008032:0.003540:0.008055:0.003257:0.003257
Kidney Int:@0.595071:0.770552:0.650621:0.770552:0.650621:0.758276:0.595071:0.758276:0.006950:0.002352:0.008055:0.007173:0.007644:0.006303:0.003257:0.002658:0.007173:0.003986
. 2014 Jan;85(1):49-61.:@0.650621:0.770552:0.775281:0.770552:0.775281:0.758276:0.650621:0.758276:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.005668:0.008032:0.007173:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
5. :@0.519035:0.781426:0.532065:0.781426:0.532065:0.769151:0.519035:0.769151:0.006515:0.003257:0.003257
Davids  MR, Jardine T, Marais  N, Jacobs JC.  south African Renal :@0.544235:0.781426:0.927058:0.781426:0.927058:0.769151:0.544235:0.769151:0.008749:0.008032:0.006515:0.002352:0.008055:0.004563:0.003257:0.002222:0.010807:0.007138:0.003257:0.005468:0.005668:0.008032:0.003540:0.008055:0.002352:0.007173:0.007644:0.005468:0.005009:0.003257:0.005468:0.010807:0.008032:0.003540:0.008032:0.002352:0.004563:0.003257:0.002222:0.008702:0.003257:0.005468:0.005668:0.008032:0.007608:0.007702:0.008020:0.004563:0.005468:0.005668:0.009560:0.003257:0.003257:0.002211:0.005856:0.007702:0.007150:0.003986:0.007173:0.005468:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.007173:0.005468:0.007138:0.007644:0.007173:0.008032:0.002352:0.003257
Registry Annual Report 2016. http://sa-renalsociety.org/.:@0.544235:0.792301:0.861524:0.792301:0.861524:0.780025:0.544235:0.780025:0.007138:0.007644:0.007914:0.002352:0.004563:0.003986:0.003540:0.006303:0.003257:0.008702:0.007173:0.007173:0.007150:0.008032:0.002352:0.003257:0.007138:0.007644:0.008020:0.007702:0.003540:0.003986:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003246:0.007173:0.003986:0.003986:0.008020:0.003257:0.005139:0.005139:0.004563:0.008032:0.003904:0.003540:0.007644:0.007173:0.008032:0.002352:0.004563:0.007702:0.007608:0.002352:0.007644:0.003986:0.006303:0.003257:0.007702:0.003540:0.007914:0.005139:0.003257
6. :@0.519035:0.803175:0.532065:0.803175:0.532065:0.790900:0.519035:0.790900:0.006515:0.003257:0.003257
Kilonzo  KG, Jones EsW, Okpechi IG, :@0.544235:0.803175:0.768402:0.803175:0.768402:0.790900:0.544235:0.790900:0.006950:0.002352:0.002352:0.007702:0.007173:0.004998:0.007702:0.003257:0.004069:0.006950:0.010254:0.003257:0.007338:0.005668:0.007702:0.007173:0.007644:0.004563:0.007338:0.006303:0.005856:0.011289:0.003257:0.007338:0.010219:0.005903:0.008020:0.007644:0.007608:0.007173:0.002352:0.007338:0.002658:0.010254:0.003257:0.003257
et al.:@0.772483:0.803175:0.805091:0.803175:0.805091:0.790900:0.772483:0.790900:0.007644:0.003986:0.007338:0.008032:0.002352:0.003257
 Disparities  in dialy-:@0.805091:0.803175:0.923801:0.803175:0.923801:0.790900:0.805091:0.790900:0.007338:0.008749:0.002352:0.004563:0.008020:0.008032:0.003540:0.002352:0.003986:0.002352:0.007644:0.004563:0.003257:0.004092:0.002352:0.007173:0.007338:0.008055:0.002352:0.008032:0.002352:0.006315:0.003904
sis allocation: An  audit from  the new  south  Africa. :@0.544235:0.814050:0.861382:0.814050:0.861382:0.801774:0.544235:0.801774:0.004563:0.002352:0.004563:0.007255:0.008032:0.002352:0.002352:0.007702:0.007608:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.007255:0.008702:0.007173:0.003257:0.003986:0.008032:0.007150:0.008055:0.002352:0.003986:0.007255:0.003692:0.003540:0.007702:0.011030:0.003257:0.003986:0.003986:0.007173:0.007644:0.007255:0.007173:0.007644:0.009772:0.003257:0.003998:0.005856:0.007702:0.007150:0.003986:0.007173:0.003257:0.003986:0.008702:0.003692:0.003540:0.002352:0.007608:0.008032:0.003257:0.003257
PloS One.:@0.865381:0.814050:0.923801:0.814050:0.923801:0.801774:0.865381:0.801774:0.006961:0.002352:0.007702:0.005856:0.007255:0.010219:0.007173:0.007644:0.003257
 :@0.923801:0.814050:0.927058:0.814050:0.927058:0.801774:0.923801:0.801774:0.003257
2017;12:e0176041.:@0.544235:0.824924:0.646341:0.824924:0.646341:0.812649:0.544235:0.812649:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.007644:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
7. :@0.519035:0.835799:0.532065:0.835799:0.532065:0.823523:0.519035:0.823523:0.006515:0.003257:0.003257
Wanner C, Inzucchi sE, Lachin JM, :@0.544235:0.835799:0.741285:0.835799:0.741285:0.823523:0.544235:0.823523:0.011289:0.008032:0.007173:0.007173:0.007644:0.003540:0.003293:0.009560:0.003257:0.003293:0.002658:0.007173:0.004998:0.007150:0.007608:0.007608:0.007173:0.002352:0.003304:0.005856:0.006303:0.003257:0.003304:0.005433:0.008032:0.007608:0.007173:0.002352:0.007173:0.003293:0.005668:0.010807:0.003257:0.003257
et al.:@0.741320:0.835799:0.769884:0.835799:0.769884:0.823523:0.741320:0.823523:0.007644:0.003986:0.003293:0.008032:0.002352:0.003257
 Empagliflozin and progres:@0.769884:0.835799:0.919908:0.835799:0.919908:0.823523:0.769884:0.823523:0.003304:0.006303:0.011030:0.008020:0.008032:0.007914:0.002352:0.002352:0.002852:0.002852:0.007702:0.004998:0.002352:0.007173:0.003304:0.008032:0.007173:0.008055:0.003304:0.008020:0.003540:0.007702:0.007914:0.003540:0.007644:0.004563
-:@0.919896:0.835799:0.923801:0.835799:0.923801:0.823523:0.919896:0.823523:0.003904
sion of kidney disease in type 2 diabetes. :@0.544235:0.846673:0.784759:0.846673:0.784759:0.834398:0.544235:0.834398:0.004563:0.002352:0.007702:0.007173:0.004033:0.007702:0.003692:0.004033:0.005903:0.002352:0.008055:0.007173:0.007644:0.006303:0.004033:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.004045:0.002352:0.007173:0.004033:0.003986:0.006303:0.008020:0.007644:0.004033:0.006515:0.004045:0.008055:0.002352:0.008032:0.008020:0.007644:0.003986:0.007644:0.004563:0.003257:0.003257
New England Journal of :@0.785559:0.846673:0.927058:0.846673:0.927058:0.834398:0.785559:0.834398:0.008702:0.007644:0.009772:0.004033:0.006303:0.007173:0.007914:0.002352:0.008032:0.007173:0.008055:0.004045:0.005668:0.007702:0.007150:0.003540:0.007173:0.008032:0.002352:0.004033:0.007702:0.003692:0.003257
Medicine.:@0.544235:0.857548:0.601127:0.857548:0.601127:0.845272:0.544235:0.845272:0.010807:0.007644:0.008055:0.002352:0.007608:0.002352:0.007173:0.007644:0.003257
 2016;375(4):323-34.:@0.601127:0.857548:0.711428:0.857548:0.711428:0.845272:0.601127:0.845272:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
8. :@0.519035:0.868422:0.532065:0.868422:0.532065:0.856147:0.519035:0.856147:0.006515:0.003257:0.003257
seedat YK, Rayner BL, Veriava Y. south African hypertension practice :@0.544235:0.868422:0.927117:0.868422:0.927117:0.856147:0.544235:0.856147:0.005739:0.007526:0.007526:0.007937:0.007914:0.003869:0.002575:0.006844:0.006832:0.003140:0.002575:0.007020:0.007914:0.006185:0.007056:0.007526:0.003422:0.002575:0.006632:0.005315:0.003140:0.002575:0.008137:0.007526:0.003422:0.002234:0.007914:0.006397:0.007914:0.002575:0.006844:0.003140:0.002575:0.005739:0.007585:0.007032:0.003869:0.007056:0.002575:0.008584:0.003575:0.003422:0.002234:0.007491:0.007914:0.007056:0.002575:0.007056:0.006185:0.007902:0.007526:0.003422:0.003869:0.007526:0.007056:0.004445:0.002234:0.007585:0.007056:0.002575:0.007902:0.003422:0.007914:0.007491:0.003869:0.002234:0.007491:0.007644:0.003257
guideline 2014. :@0.544235:0.879297:0.630936:0.879297:0.630936:0.867021:0.544235:0.867021:0.007796:0.007032:0.002234:0.007937:0.007526:0.002234:0.002234:0.007056:0.007526:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.003257
Cardiovascular Journal of Africa.:@0.630819:0.879297:0.814051:0.879297:0.814051:0.867021:0.630819:0.867021:0.009443:0.007914:0.003422:0.007937:0.002234:0.007585:0.006397:0.007914:0.004445:0.007491:0.007032:0.002234:0.007914:0.003422:0.003140:0.005550:0.007585:0.007032:0.003422:0.007056:0.007914:0.002234:0.003140:0.007585:0.003575:0.003140:0.008584:0.003575:0.003422:0.002234:0.007491:0.007914:0.003257
 2014;25(6):288-94.:@0.813934:0.879297:0.915604:0.879297:0.915604:0.867021:0.813934:0.867021:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.006397:0.003786:0.006397:0.006397:0.003257
9. :@0.519035:0.890171:0.532065:0.890171:0.532065:0.877896:0.519035:0.877896:0.006515:0.003257:0.003257
Whelton pK, Carey RM, Aronow Ws, :@0.544235:0.890171:0.755878:0.890171:0.755878:0.877896:0.544235:0.877896:0.011289:0.007173:0.007644:0.002352:0.003986:0.007702:0.007173:0.004527:0.006961:0.006950:0.003257:0.004527:0.009560:0.008032:0.003540:0.007644:0.006303:0.004527:0.007138:0.010807:0.003257:0.004527:0.008702:0.003540:0.007702:0.007173:0.007702:0.009772:0.004516:0.011289:0.005856:0.003257:0.003257
et al:@0.757148:0.890171:0.783689:0.890171:0.783689:0.877896:0.757148:0.877896:0.007644:0.003986:0.004527:0.008032:0.002352
. 2017 ACC/AHA/AApA/:@0.783689:0.890171:0.923812:0.890171:0.923812:0.877896:0.783689:0.877896:0.003257:0.004527:0.006515:0.006515:0.006515:0.006515:0.004539:0.008702:0.009560:0.009560:0.005139:0.008702:0.008032:0.008702:0.005139:0.008702:0.008702:0.006961:0.008702:0.005139
ABC/ACpM/AGs/AphA/AsH/AspC/NMA/pCNA  Guideline for  the :@0.544235:0.901046:0.927058:0.901046:0.927058:0.888771:0.544235:0.888771:0.008702:0.006750:0.009560:0.005139:0.008702:0.009560:0.006961:0.010807:0.005139:0.008702:0.010254:0.005856:0.005139:0.008702:0.006961:0.007173:0.008702:0.005139:0.008702:0.005856:0.008032:0.005139:0.008702:0.005856:0.006961:0.009560:0.005139:0.008702:0.010807:0.008702:0.005139:0.006961:0.009560:0.008702:0.008702:0.003257:0.003951:0.010254:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.007244:0.003692:0.007702:0.003540:0.003257:0.003975:0.003986:0.007173:0.007644:0.003257
prevention,  detection,  evaluation, and management  of high :@0.544235:0.911920:0.927058:0.911920:0.927058:0.899645:0.544235:0.899645:0.008020:0.003540:0.007644:0.006515:0.007644:0.007173:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257:0.005409:0.008055:0.007644:0.003986:0.007644:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257:0.005409:0.007644:0.006515:0.008032:0.002352:0.007150:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.008678:0.008032:0.007173:0.008055:0.008678:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257:0.005409:0.007702:0.003692:0.008678:0.007173:0.002352:0.007914:0.007173:0.003257
blood pressure in adults: A report of the American College of Car-:@0.544235:0.922795:0.923777:0.922795:0.923777:0.910520:0.544235:0.910520:0.008020:0.002352:0.007702:0.007702:0.008055:0.003739:0.008020:0.003540:0.007644:0.004563:0.004563:0.007150:0.003540:0.007644:0.003739:0.002352:0.007173:0.003739:0.008032:0.008055:0.007150:0.002352:0.003986:0.004563:0.003257:0.003739:0.008702:0.003739:0.003540:0.007644:0.008020:0.007702:0.003540:0.003986:0.003728:0.007702:0.003692:0.003739:0.003986:0.007173:0.007644:0.003739:0.008702:0.011030:0.007644:0.003540:0.002352:0.007608:0.008032:0.007173:0.003739:0.009560:0.007702:0.002352:0.002352:0.007644:0.007914:0.007644:0.003739:0.007702:0.003692:0.003739:0.009560:0.008032:0.003540:0.003904
diology/American Heart Association Task Force on Clinical practice :@0.544235:0.933669:0.927058:0.933669:0.927058:0.921394:0.544235:0.921394:0.008055:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.005139:0.008702:0.011030:0.007644:0.003540:0.002352:0.007608:0.008032:0.007173:0.002846:0.008032:0.007644:0.008032:0.003540:0.003986:0.002846:0.008702:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.002846:0.005009:0.008032:0.004563:0.005903:0.002846:0.005703:0.007702:0.003540:0.007608:0.007644:0.002834:0.007702:0.007173:0.002846:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.002846:0.006961:0.003540:0.008032:0.007608:0.003986:0.002352:0.007608:0.007644:0.003257
Guidelines. :@0.544235:0.944670:0.610287:0.944670:0.610287:0.932394:0.544235:0.932394:0.010254:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.003257:0.003257
Hypertension:@0.610287:0.944670:0.684417:0.944670:0.684417:0.932394:0.610287:0.932394:0.008032:0.006303:0.008020:0.007644:0.003540:0.003986:0.007644:0.007173:0.004563:0.002352:0.007702:0.007173
. 2017.:@0.684417:0.944670:0.720248:0.944670:0.720248:0.932394:0.684417:0.932394:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257